Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.

Rupp R, Hurley D, Grayson S, Li J, Nolan K, McFetridge RD, Hartzel J, Abeygunawardana C, Winters M, Pujar H, Benner P, Musey L.

Hum Vaccin Immunother. 2019;15(3):549-559. doi: 10.1080/21645515.2019.1568159. Epub 2019 Feb 15.

PMID:
30689507
2.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Peterson JT, Stacey HL, MacNair JE, Li J, Hartzel JS, Sterling TM, Benner P, Tamms GM, Musey LK.

Hum Vaccin Immunother. 2019;15(3):540-548. doi: 10.1080/21645515.2018.1532250. Epub 2018 Nov 14.

PMID:
30427749
3.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.

Greenberg D, Hoover PA, Vesikari T, Peltier C, Hurley DC, McFetridge RD, Dallas M, Hartzel J, Marchese RD, Coller BG, Stek JE, Abeygunawardana C, Winters MA, MacNair JE, Pujar NS, Musey L.

Vaccine. 2018 Oct 29;36(45):6883-6891. doi: 10.1016/j.vaccine.2018.02.113. Epub 2018 Sep 21.

PMID:
30244873
4.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age.

Ermlich SJ, Andrews CP, Folkerth S, Rupp R, Greenberg D, McFetridge RD, Hartzel J, Marchese RD, Stek JE, Abeygunawardana C, Musey LK.

Vaccine. 2018 Oct 29;36(45):6875-6882. doi: 10.1016/j.vaccine.2018.03.012. Epub 2018 Mar 17.

PMID:
29559167
5.

Safety and Immunogenicity of M-M-RII (Combination Measles-Mumps-Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009.

Kuter BJ, Brown M, Wiedmann RT, Hartzel J, Musey L.

Pediatr Infect Dis J. 2016 Sep;35(9):1011-20. doi: 10.1097/INF.0000000000001241.

PMID:
27254037
6.

A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.

Marshall GS, Senders SD, Shepard J, Twiggs JD, Gardner J, Hille D, Hartzel J, Valenzuela R, Stek JE, Helmond FA.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2188-2196. Epub 2016 May 5.

7.

Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.

McFetridge R, Meulen AS, Folkerth SD, Hoekstra JA, Dallas M, Hoover PA, Marchese RD, Zacholski DM, Watson WJ, Stek JE, Hartzel JS, Musey LK.

Vaccine. 2015 Jun 4;33(24):2793-9. doi: 10.1016/j.vaccine.2015.04.025. Epub 2015 Apr 23.

PMID:
25913828
8.

M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.

Wiedmann RT, Reisinger KS, Hartzel J, Malacaman E, Senders SD, Giacoletti KE, Shaw E, Kuter BJ, Schödel F, Musey LK.

Vaccine. 2015 Apr 27;33(18):2132-40. doi: 10.1016/j.vaccine.2015.03.017. Epub 2015 Mar 18.

PMID:
25796337
9.

Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine.

Sobanjo-ter Meulen A, Vesikari T, Malacaman EA, Shapiro SA, Dallas MJ, Hoover PA, McFetridge R, Stek JE, Marchese RD, Hartzel J, Watson WJ, Musey LK.

Pediatr Infect Dis J. 2015 Feb;34(2):186-94. doi: 10.1097/INF.0000000000000516.

PMID:
25741971
10.

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine.

Allen KB, Fowler VG Jr, Gammie JS, Hartzel JS, Onorato MT, DiNubile MJ, Sobanjo-Ter Meulen A.

Open Forum Infect Dis. 2014 Aug 26;1(2):ofu071. doi: 10.1093/ofid/ofu071. eCollection 2014 Sep.

11.

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors.

McNeely TB, Shah NA, Fridman A, Joshi A, Hartzel JS, Keshari RS, Lupu F, DiNubile MJ.

Hum Vaccin Immunother. 2014;10(12):3513-6. doi: 10.4161/hv.34407.

12.

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, Corey GR, Carmeli Y, Betts R, Hartzel JS, Chan IS, McNeely TB, Kartsonis NA, Guris D, Onorato MT, Smugar SS, DiNubile MJ, Sobanjo-ter Meulen A.

JAMA. 2013 Apr 3;309(13):1368-78. doi: 10.1001/jama.2013.3010.

PMID:
23549582
13.

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

Moustafa M, Aronoff GR, Chandran C, Hartzel JS, Smugar SS, Galphin CM, Mailloux LU, Brown E, Dinubile MJ, Kartsonis NA, Guris D.

Clin Vaccine Immunol. 2012 Sep;19(9):1509-16. doi: 10.1128/CVI.00034-12. Epub 2012 Jul 25.

14.

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.

Harro CD, Betts RF, Hartzel JS, Onorato MT, Lipka J, Smugar SS, Kartsonis NA.

Vaccine. 2012 Feb 21;30(9):1729-36. doi: 10.1016/j.vaccine.2011.12.045. Epub 2011 Dec 20.

PMID:
22192849
15.

Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Harro C, Betts R, Orenstein W, Kwak EJ, Greenberg HE, Onorato MT, Hartzel J, Lipka J, DiNubile MJ, Kartsonis N.

Clin Vaccine Immunol. 2010 Dec;17(12):1868-74. doi: 10.1128/CVI.00356-10. Epub 2010 Oct 13.

16.

Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).

Bernstein HH, Eves K, Campbell K, Black SB, Twiggs JD, Reisinger KS, Conti RM, Flodmark CE, Rombo L, Klopfer S, Schödel F, Hartzel J, Kuter BJ; Refrigerator-Stable Formulation Study Group for ProQuad.

Pediatrics. 2007 Jun;119(6):e1299-305. Epub 2007 May 14.

PMID:
17502347
17.

Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).

Kuter BJ, Brown ML, Hartzel J, Williams WR, EvesiKaren A, Black S, Shinefield H, Reisinger KS, Marchant CD, Sullivan BJ, Thear M, Klopfer S, Xu J, Gress JO, Schödel F; Study Group for ProQuad.

Hum Vaccin. 2006 Sep-Oct;2(5):205-14.

PMID:
17035730
18.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
19.

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, Xu J, Hartzel J, Evans B, Digilio L, Schödel F, Brown ML, Kuter B; 013 Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Apr;25(4):287-92.

PMID:
16567978
20.

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I; Study Group for Varivax.

Pediatr Infect Dis J. 2004 Feb;23(2):132-7.

PMID:
14872179
21.

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.

Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, Lin TY, Lee BW, Kwan K, Kasim SM, Chan CY, Kaplan KM, Distefano DJ, Harmon AL, Golie A, Hartzel J, Xu J, Li S, Matthews H, Sadoff JC, Shaw A.

Vaccine. 2002 Jul 26;20(23-24):2942-9.

PMID:
12126906
22.

Strategies for comparing treatments on a binary response with multi-centre data.

Agresti A, Hartzel J.

Stat Med. 2000 Apr 30;19(8):1115-39. Review.

PMID:
10790684
24.

Caudal slope of the tibia and its relationship to noncontact injuries to the ACL.

Meister K, Talley MC, Horodyski MB, Indelicato PA, Hartzel JS, Batts J.

Am J Knee Surg. 1998 Fall;11(4):217-9.

PMID:
9853999
25.

Continuous passive motion after repair of the rotator cuff. A prospective outcome study.

Lastayo PC, Wright T, Jaffe R, Hartzel J.

J Bone Joint Surg Am. 1998 Jul;80(7):1002-11.

PMID:
9698005
26.

Owner satisfaction with partial mandibulectomy or maxillectomy for treatment of oral tumors in 27 dogs.

Fox LE, Geoghegan SL, Davis LH, Hartzel JS, Kubilis P, Gruber LA.

J Am Anim Hosp Assoc. 1997 Jan-Feb;33(1):25-31.

PMID:
8974022
27.

Population-averaged and cluster-specific models for clustered ordinal response data.

Ten Have TR, Landis JR, Hartzel J.

Stat Med. 1996 Dec 15;15(23):2573-88.

PMID:
8961464
28.

The impact of 2D versus 3D quantitation of tumor bulk determination on current methods of assessing response to treatment.

Hopper KD, Kasales CJ, Eggli KD, TenHave TR, Belman NM, Potok PS, Van Slyke MA, Olt GJ, Close P, Lipton A, Harvey HA, Hartzel JS.

J Comput Assist Tomogr. 1996 Nov-Dec;20(6):930-7.

PMID:
8933793
29.

The quality of 3D reconstructions from 1.0 and 1.5 pitch helical and conventional CT.

Hopper KD, Pierantozzi D, Potok PS, Kasales CJ, TenHave TR, Meilstrup JW, Van Slyke MA, Mahraj R, Westacott S, Hartzel JS.

J Comput Assist Tomogr. 1996 Sep-Oct;20(5):841-7.

PMID:
8797930
30.

Take-home informed consent for intravenous contrast media: do patients learn more?

Neptune SM, Hopper KD, Houts PS, Hartzel JS, Ten Have TR, Loges RJ 3rd.

Invest Radiol. 1996 Feb;31(2):109-13.

PMID:
8750446
31.

Multiple fine-needle biopsies using a coaxial technique: efficacy and a comparison of three methods.

Hopper KD, Abendroth CS, TenHave TR, Hartzel J, Savage CA.

Cardiovasc Intervent Radiol. 1995 Sep-Oct;18(5):307-11.

PMID:
8846470
32.

Fine-needle aspiration biopsy versus fine-needle capillary (nonaspiration) biopsy: in vivo comparison.

Savage CA, Hopper KD, Abendroth CS, Hartzel JS, TenHave TR.

Radiology. 1995 Jun;195(3):815-9.

PMID:
7754015
33.

Informed consent forms for clinical and research imaging procedures: how much do patients understand?

Hopper KD, TenHave TR, Hartzel J.

AJR Am J Roentgenol. 1995 Feb;164(2):493-6.

PMID:
7839996
34.

Percutaneous biopsy of the liver and kidney by using coaxial technique: adequacy of the specimen obtained with three different needles in vitro.

Hopper KD, Grenko RT, TenHave TR, Hartzel J, Sturtz KW, Savage CA.

AJR Am J Roentgenol. 1995 Jan;164(1):221-4.

PMID:
7998543
35.

CT percutaneous biopsy guns: comparison of end-cut and side-notch devices in cadaveric specimens.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Hartzel JS, Potok PS.

AJR Am J Roentgenol. 1995 Jan;164(1):195-9.

PMID:
7998539
36.

The effect of informed consent on the level of anxiety in patients given i.v. contrast material.

Hopper KD, Houts PS, TenHave TR, Matthews YL, Colon E, Haseman DB, Hartzel J.

AJR Am J Roentgenol. 1994 Mar;162(3):531-5.

PMID:
8109491

Supplemental Content

Loading ...
Support Center